These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24024428)

  • 21. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.
    Bobadilla JL; Farrell MH; Farrell PM
    Adv Pediatr; 2002; 49():131-90. PubMed ID: 12214770
    [No Abstract]   [Full Text] [Related]  

  • 22. A disease called 'sixty-five roses'.
    Nat Struct Biol; 2002 Dec; 9(12):887. PubMed ID: 12447350
    [No Abstract]   [Full Text] [Related]  

  • 23. [National program for neonatal screening for cystic fibrosis: implementation and preliminary results].
    Navarro J; Grosskopf C; Vidailhet M; Briard ML; Farriaux JP
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S56-60. PubMed ID: 12592165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis.
    Hubert D; Fajac I; Bienvenu T; Desmazes-Dufeu N; Ellaffi M; Dall'Ava-Santucci J; Dusser D
    J Cyst Fibros; 2004 Aug; 3(3):203. PubMed ID: 15463911
    [No Abstract]   [Full Text] [Related]  

  • 25. First study of the F508del mutation in Malaysian children diagnosed with cystic fibrosis.
    Nathan AM; Thong MK; deBruyne J; Ariffin H
    J Paediatr Child Health; 2011 Aug; 47(8):573-5. PubMed ID: 21843195
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene symbol: CFTR. Disease: Cystic fibrosis.
    Trujillo-Tiebas MJ; Gallego J; García M; Lorda-Sanchez I; Ramos C; Ayuso C
    Hum Genet; 2004 Mar; 114(4):403. PubMed ID: 15046061
    [No Abstract]   [Full Text] [Related]  

  • 27. CFTR gene analysis in cystic fibrosis patients: detection of 91% of molecular defects and identification of the novel mutation D979V.
    Plouvier E; Cougoureux E; Sardet A; Tournier G; Aymard P; Feldmann D
    Ann Genet; 1997; 40(3):185-8. PubMed ID: 9401110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this cystic fibrosis transmembrane conductance regulator mutation does not cause cystic fibrosis.
    Derichs N; Schuster A; Grund I; Ernsting A; Stolpe C; Körtge-Jung S; Gallati S; Stuhrmann M; Kozlowski P; Ballmann M
    Clin Genet; 2005 Jun; 67(6):529-31. PubMed ID: 15857421
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cystic fibrosis and neonatal screening].
    Nau JY
    Rev Med Suisse; 2007 May; 3(110):1212. PubMed ID: 17564353
    [No Abstract]   [Full Text] [Related]  

  • 30. Current progress in cystic fibrosis: is this a disease elusive to therapy?
    Brown C
    Pulm Pharmacol Ther; 2008 Aug; 21(4):585-7. PubMed ID: 18313958
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of preimplantation genetic diagnosis (PGD) for the cystic fibrosis mutation delta F508 by fluorescent polymerase chain reaction.
    Moutou C; Viville S
    Prenat Diagn; 1999 Dec; 19(13):1248-50. PubMed ID: 10660962
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel exon duplication of the cystic fibrosis transmembrane conductance regulator in a patient presenting with adult-onset recurrent pancreatitis.
    Kopp BT; Pastore MT; Sturm AC; Holtzlander MJ; Westman JA
    Pancreas; 2011 Jul; 40(5):773-7. PubMed ID: 21673536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovations in the treatment of cystic fibrosis: outriders for the treatment of diseases with other genetic defects?
    Schubert-Zsilavecz M; Merk D
    Future Med Chem; 2011 Dec; 3(16):1969-70. PubMed ID: 22098344
    [No Abstract]   [Full Text] [Related]  

  • 35. [From gene to disease; from defective chloride ion transport to cystic fibrosis].
    Scheffer H; van den Ouweland AM; Veeze HJ
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):686-7. PubMed ID: 11530706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [First diagnosis of cystic fibrosis in Afghanistan and description of a new mutation].
    Vic P; Manalai GG; Labat F; Sabet W; Leis A; Ferec C
    Arch Pediatr; 2010 Feb; 17(2):180-1. PubMed ID: 20018497
    [No Abstract]   [Full Text] [Related]  

  • 37. A new frameshift mutation 460delG in exon 4 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Wagner K; Schneditz P; Rosenkranz W
    Hum Mutat; 1996; 7(2):183. PubMed ID: 8829644
    [No Abstract]   [Full Text] [Related]  

  • 38. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
    Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
    Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
    [No Abstract]   [Full Text] [Related]  

  • 39. Two novel frameshift deletions (1924del7, 2055del9-->A) in the CFTR gene in Mexican cystic fibrosis patients.
    Orozco L; Zielenski J; Markiewicz D; Villarreal T; Tsui LC; Lezana JL; del Angel RM
    Hum Mutat; 1997; 10(3):239-40. PubMed ID: 9298826
    [No Abstract]   [Full Text] [Related]  

  • 40. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator I1234V mutation.
    Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
    Saudi Med J; 2009 Aug; 30(8):1101-2. PubMed ID: 19668897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.